Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kairos Pharma, LTD. | VP of Research and Development | COMMON STOCK | 133K | Sep 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KAPA | Kairos Pharma, LTD. | Sep 16, 2024 | 0 | $0 | 3 | Sep 24, 2024 | VP of Research and Development |